Patients

Cut the uncertainty, not the patient

If your doctor could tell you if an atypical mole or dark spot on your skin was positive for melanoma associated gene expression, without cutting your skin, would you want to know more?

What is the PLA?

The PLA is a test that helps your doctor diagnose melanoma, the most deadly form of skin cancer, without the use of a scalpel. The PLA detects two genes which are elevated in melanoma skin cancer.

How does it work?

DermTech’s PLA uses a sample collected with an adhesive patch and helps your doctor assess moles or dark colored skin spots for melanoma skin cancer with minimal discomfort. This adhesive patch biopsies your skin non-invasively, without the traditional surgical procedure.

Is it right for me?

DermTech’s PLA and Adhesive Skin Collection Kit is used to identify lesions at high risk for melanoma. This accurate genomics test makes it easier to correctly identifying early stage melanoma and reduces the number of unnecessary surgical biopsies.

Is it Melanoma?

“I was diagnosed with an in-situ melanoma in 2009 while in my early 30’s. I’ve had countless biopsies. Many have left nasty scars and none have been melanoma again. On my last derm visit the doctor used the DermTech patch biopsy. We were both excited to have this option to get pathology results without an incision. The pathology came back negative. Just what I like to hear!” – Laurel in CO

Skin cancer is the most common form of cancer in the United States.

Skin cancer’s deadliest form, melanoma, is responsible for nearly 10,000 deaths each year. If caught in early stage, the prognosis is good, but once lesions develop to a depth over four millimeters, the five-year survival drops to <50%. For this reason, identifying high risk pigmented lesions early can have a significant impact on patient outcomes.